Innate immunity and effector and regulatory mechanisms involved in allergic contact dermatitis
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | SILVESTRE, Marilene Chaves | |
dc.contributor.author | SATO, Maria Notomi | |
dc.contributor.author | REIS, Vitor Manoel Silva dos | |
dc.date.accessioned | 2018-07-05T18:02:30Z | |
dc.date.available | 2018-07-05T18:02:30Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Skin's innate immunity is the initial activator of immune response mechanisms, influencing the development of adaptive immunity. Some contact allergens are detected by Toll-like receptors (TLRs) and inflammasome NLR3. Keratinocytes participate in innate immunity and, in addition to functioning as an anatomical barrier, secrete cytokines, such as TNF, IL-1 beta, and IL-18, contributing to the development of Allergic Contact Dermatitis. Dendritic cells recognize and process antigenic peptides into T cells. Neutrophils cause pro-inflammatory reactions, mast cells induce migration/maturation of skin DCs, the natural killer cells have natural cytotoxic capacity, the gamma delta T cells favor contact with hapten during the sensitization phase, and the innate lymphoid cells act in the early stages by secreting cytokines, as well as act in inflammation and tissue homeostasis. The antigen-specific inflammation is mediated by T cells, and each subtype of T cells (Th1/Tc1, Th2/Tc2, and Th17/Tc17) activates resident skin cells, thus contributing to inflammation. Skin's regulatory T cells have a strong ability to inhibit the proliferation of hapten-specific T cells, acting at the end of the Allergic Contact Dermatitis response and in the control of systemic immune responses. In this review, we report how cutaneous innate immunity is the first line of defense and focus its role in the activation of the adaptive immune response, with effector response induction and its regulation. | |
dc.description.index | MEDLINE | |
dc.identifier.citation | ANAIS BRASILEIROS DE DERMATOLOGIA, v.93, n.2, p.242-250, 2018 | |
dc.identifier.doi | 10.1590/abd1806-4841.20186340 | |
dc.identifier.eissn | 1806-4841 | |
dc.identifier.issn | 0365-0596 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/26933 | |
dc.language.iso | eng | |
dc.publisher | SOC BRASILEIRA DERMATOLOGIA | |
dc.relation.ispartof | Anais Brasileiros de Dermatologia | |
dc.rights | openAccess | |
dc.rights.holder | Copyright SOC BRASILEIRA DERMATOLOGIA | |
dc.subject | Allergy and immunology | |
dc.subject | Dermatitis | |
dc.subject | allergic contact | |
dc.subject | Dermatitis | |
dc.subject | contact | |
dc.subject.other | plasmacytoid dendritic cells | |
dc.subject.other | cd8 t-cells | |
dc.subject.other | langerhans cells | |
dc.subject.other | lymphoid-cells | |
dc.subject.other | viral-infection | |
dc.subject.other | human keratinocytes | |
dc.subject.other | adaptive immunity | |
dc.subject.other | cutting edge | |
dc.subject.other | i interferon | |
dc.subject.other | human skin | |
dc.subject.wos | Dermatology | |
dc.title | Innate immunity and effector and regulatory mechanisms involved in allergic contact dermatitis | |
dc.type | article | |
dc.type.category | review | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.author.external | SILVESTRE, Marilene Chaves:Univ Fed Goias, Dematol Serv, Dept Trop Med & Dematol, Goiania, Go, Brazil | |
hcfmusp.citation.scopus | 32 | |
hcfmusp.contributor.author-fmusphc | MARIA NOTOMI SATO | |
hcfmusp.contributor.author-fmusphc | VITOR MANOEL SILVA DOS REIS | |
hcfmusp.description.beginpage | 242 | |
hcfmusp.description.endpage | 250 | |
hcfmusp.description.issue | 2 | |
hcfmusp.description.volume | 93 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 29723367 | |
hcfmusp.origem.scielo | SCIELO:S0365-05962018000200242 | |
hcfmusp.origem.scopus | 2-s2.0-85046417746 | |
hcfmusp.origem.wos | WOS:000431299700013 | |
hcfmusp.publisher.city | RIO DE JANEIRO RJ | |
hcfmusp.publisher.country | BRAZIL | |
hcfmusp.relation.reference | Albanesi C, 2000, J INVEST DERMATOL, V115, P81, DOI 10.1046/j.1523-1747.2000.00041.x | |
hcfmusp.relation.reference | Albanesi Cristina, 2005, Current Drug Targets - Inflammation and Allergy, V4, P329, DOI 10.2174/1568010054022033 | |
hcfmusp.relation.reference | Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189 | |
hcfmusp.relation.reference | Boyman O, 2007, TRENDS IMMUNOL, V28, P51, DOI 10.1016/j.it.2006.12.005 | |
hcfmusp.relation.reference | Brodsky I, 2007, CELL, V130, P979, DOI 10.1016/j.cell.2007.09.009 | |
hcfmusp.relation.reference | Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966 | |
hcfmusp.relation.reference | Carbone T, 2010, J IMMUNOL, V184, P1102, DOI 10.4049/jimmunol.0902518 | |
hcfmusp.relation.reference | Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755 | |
hcfmusp.relation.reference | Chow Z, 2013, J IMMUNOL, V191, P3049, DOI 10.4049/jimmunol.1203205 | |
hcfmusp.relation.reference | Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047 | |
hcfmusp.relation.reference | Corsini E, 2000, TOXICOLOGY, V142, P203, DOI 10.1016/S0300-483X(99)00145-6 | |
hcfmusp.relation.reference | Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512 | |
hcfmusp.relation.reference | Di Santo JP, 2008, EUR J IMMUNOL, V38, P2948, DOI 10.1002/eji.200838830 | |
hcfmusp.relation.reference | Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028 | |
hcfmusp.relation.reference | Egawa G, 2011, J INVEST DERMATOL, V131, P2178, DOI 10.1038/jid.2011.198 | |
hcfmusp.relation.reference | Engeman T, 2004, J LEUKOCYTE BIOL, V76, P941, DOI 10.1189/jlb.0304193 | |
hcfmusp.relation.reference | Fukunaga A, 2008, J IMMUNOL, V180, P3057, DOI 10.4049/jimmunol.180.5.3057 | |
hcfmusp.relation.reference | Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358 | |
hcfmusp.relation.reference | Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733 | |
hcfmusp.relation.reference | Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783 | |
hcfmusp.relation.reference | Gratz IK, 2013, ANN NY ACAD SCI, V1283, P8, DOI 10.1111/nyas.12011 | |
hcfmusp.relation.reference | Gratz IK, 2013, J IMMUNOL, V190, P4483, DOI 10.4049/jimmunol.1300212 | |
hcfmusp.relation.reference | Gri G, 2008, IMMUNITY, V29, P771, DOI 10.1016/j.immuni.2008.08.018 | |
hcfmusp.relation.reference | He DG, 2009, J IMMUNOL, V183, P1463, DOI 10.4049/jimmunol.0804108 | |
hcfmusp.relation.reference | Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157 | |
hcfmusp.relation.reference | Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284 | |
hcfmusp.relation.reference | Honda T, 2011, J DERMATOL SCI, V63, P75, DOI 10.1016/j.jdermsci.2011.06.004 | |
hcfmusp.relation.reference | Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005 | |
hcfmusp.relation.reference | Ishizaki K, 2007, J IMMUNOL, V178, P605, DOI 10.4049/jimmunol.178.1.605 | |
hcfmusp.relation.reference | Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709 | |
hcfmusp.relation.reference | Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5 | |
hcfmusp.relation.reference | Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872 | |
hcfmusp.relation.reference | Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150 | |
hcfmusp.relation.reference | Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863 | |
hcfmusp.relation.reference | Kawamura T, 2014, J DERMATOL SCI, V75, P159, DOI 10.1016/j.jdermsci.2014.05.004 | |
hcfmusp.relation.reference | Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374 | |
hcfmusp.relation.reference | Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004 | |
hcfmusp.relation.reference | Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030 | |
hcfmusp.relation.reference | Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821 | |
hcfmusp.relation.reference | Larsen JM, 2009, J ALLERGY CLIN IMMUN, V123, P486, DOI 10.1016/j.jaci.2008.09.036 | |
hcfmusp.relation.reference | Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530 | |
hcfmusp.relation.reference | Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024 | |
hcfmusp.relation.reference | Marshall JS, 2003, CURR PHARM DESIGN, V9, P11, DOI 10.2174/1381612033392413 | |
hcfmusp.relation.reference | Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x | |
hcfmusp.relation.reference | Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509 | |
hcfmusp.relation.reference | Martin SF, 2015, CONTACT DERMATITIS, V72, P2, DOI 10.1111/cod.12311 | |
hcfmusp.relation.reference | Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715 | |
hcfmusp.relation.reference | Martins LEAM, 2011, AN BRAS DERMATOL, V86, P410 | |
hcfmusp.relation.reference | Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5 | |
hcfmusp.relation.reference | Mitsui G, 2003, IMMUNOL LETT, V86, P191, DOI 10.1016/S0165-2478(03)00017-8 | |
hcfmusp.relation.reference | Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170 | |
hcfmusp.relation.reference | Mori T, 2008, J INVEST DERMATOL, V128, P1719, DOI 10.1038/jid.2008.5 | |
hcfmusp.relation.reference | Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900 | |
hcfmusp.relation.reference | Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622 | |
hcfmusp.relation.reference | Nishibu A, 2007, J DERMATOL SCI, V45, P23, DOI 10.1016/j.jdermsci.2006.10.003 | |
hcfmusp.relation.reference | Paiva-Oliveira E. L., 2012, Revista de Ciencias Medicas e Biologicas, V11, P96 | |
hcfmusp.relation.reference | Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032 | |
hcfmusp.relation.reference | Pennino D, 2010, J IMMUNOL, V184, P4880, DOI 10.4049/jimmunol.0901767 | |
hcfmusp.relation.reference | Randolph GJ, 2001, SEMIN IMMUNOL, V13, P267, DOI 10.1006/smim.2001.0322 | |
hcfmusp.relation.reference | Ricciardi L, 2009, CONTACT DERMATITIS, V60, P57, DOI 10.1111/j.1600-0536.2008.01454.x | |
hcfmusp.relation.reference | Ring S, 2009, J ALLERGY CLIN IMMUN, V123, P1287, DOI 10.1016/j.jaci.2009.03.022 | |
hcfmusp.relation.reference | Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932 | |
hcfmusp.relation.reference | Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x | |
hcfmusp.relation.reference | Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x | |
hcfmusp.relation.reference | Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785 | |
hcfmusp.relation.reference | Salimi M, 2014, BMC DERMATOL, V14, DOI 10.1186/1471-5945-14-18 | |
hcfmusp.relation.reference | Sampaio SAP, 2007, DERMATOLOGICA, P189 | |
hcfmusp.relation.reference | Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777 | |
hcfmusp.relation.reference | Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x | |
hcfmusp.relation.reference | Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919 | |
hcfmusp.relation.reference | Sebastiani S, 2002, ARCH DERMATOL RES, V293, P552, DOI 10.1007/s00403-001-0276-9 | |
hcfmusp.relation.reference | Simon D, 2014, ALLERGY, V69, P125, DOI 10.1111/all.12351 | |
hcfmusp.relation.reference | Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365 | |
hcfmusp.relation.reference | Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630 | |
hcfmusp.relation.reference | Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783 | |
hcfmusp.relation.reference | Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926 | |
hcfmusp.relation.reference | Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787 | |
hcfmusp.relation.reference | Traidl C, 2000, J IMMUNOL, V165, P3058, DOI 10.4049/jimmunol.165.6.3058 | |
hcfmusp.relation.reference | Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x | |
hcfmusp.relation.reference | Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869 | |
hcfmusp.relation.reference | Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819 | |
hcfmusp.relation.reference | Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557 | |
hcfmusp.relation.reference | Weber FC, 2015, J EXP MED, V212, P15, DOI 10.1084/jem.20130062 | |
hcfmusp.scopus.lastupdate | 2024-05-18 | |
relation.isAuthorOfPublication | c5fbfe7f-eec0-49ea-be33-ce5f13cc3dfb | |
relation.isAuthorOfPublication | 5b0c1b8d-5f89-4dbe-b066-d20b1b6328f9 | |
relation.isAuthorOfPublication.latestForDiscovery | c5fbfe7f-eec0-49ea-be33-ce5f13cc3dfb |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_SILVESTRE_Innate_immunity_and_effector_and_regulatory_mechanisms_involved_2018.PDF
- Tamanho:
- 520.96 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)